Measuring responses to therapy in headache patients: New and traditional end-points

D. D'Amico, L. Grazzi, S. Usai, A. Rigamonti, A. Solari, G. Bussone

Research output: Contribution to journalArticle

Abstract

Changes in numerical indices of the intensity, duration and frequency of attacks are traditionally used to assess the effectiveness of treatments for migraine and other primary headaches. However, recent clinical and therapeutic guidelines and guidelines for conducting clinical trials specify that the essential aim of symptomatic and prophylactic migraine treatments should be to reduce the global impact of the headaches on the patient's life. Some standardised instruments for assessing disability and health-related quality of life seem sensitive to treatment-induced changes in primary headache patients. However, further studies to determine the suitability of these instruments as outcome measures in clinical practice are necessary.

Original languageEnglish
JournalNeurological Sciences
Volume25
Issue numberSUPPL. 3
DOIs
Publication statusPublished - Oct 2004

Fingerprint

Headache
Migraine Disorders
Guidelines
Therapeutics
Quality of Life
Outcome Assessment (Health Care)
Clinical Trials

Keywords

  • End-point
  • Migraine
  • Outcome
  • Primary headaches
  • Prophylaxis
  • Symptomatic treatments

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Measuring responses to therapy in headache patients : New and traditional end-points. / D'Amico, D.; Grazzi, L.; Usai, S.; Rigamonti, A.; Solari, A.; Bussone, G.

In: Neurological Sciences, Vol. 25, No. SUPPL. 3, 10.2004.

Research output: Contribution to journalArticle

@article{903f34dfb6fa4afe99e45d7db37dbdc4,
title = "Measuring responses to therapy in headache patients: New and traditional end-points",
abstract = "Changes in numerical indices of the intensity, duration and frequency of attacks are traditionally used to assess the effectiveness of treatments for migraine and other primary headaches. However, recent clinical and therapeutic guidelines and guidelines for conducting clinical trials specify that the essential aim of symptomatic and prophylactic migraine treatments should be to reduce the global impact of the headaches on the patient's life. Some standardised instruments for assessing disability and health-related quality of life seem sensitive to treatment-induced changes in primary headache patients. However, further studies to determine the suitability of these instruments as outcome measures in clinical practice are necessary.",
keywords = "End-point, Migraine, Outcome, Primary headaches, Prophylaxis, Symptomatic treatments",
author = "D. D'Amico and L. Grazzi and S. Usai and A. Rigamonti and A. Solari and G. Bussone",
year = "2004",
month = "10",
doi = "10.1007/s10072-004-0264-x",
language = "English",
volume = "25",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Measuring responses to therapy in headache patients

T2 - New and traditional end-points

AU - D'Amico, D.

AU - Grazzi, L.

AU - Usai, S.

AU - Rigamonti, A.

AU - Solari, A.

AU - Bussone, G.

PY - 2004/10

Y1 - 2004/10

N2 - Changes in numerical indices of the intensity, duration and frequency of attacks are traditionally used to assess the effectiveness of treatments for migraine and other primary headaches. However, recent clinical and therapeutic guidelines and guidelines for conducting clinical trials specify that the essential aim of symptomatic and prophylactic migraine treatments should be to reduce the global impact of the headaches on the patient's life. Some standardised instruments for assessing disability and health-related quality of life seem sensitive to treatment-induced changes in primary headache patients. However, further studies to determine the suitability of these instruments as outcome measures in clinical practice are necessary.

AB - Changes in numerical indices of the intensity, duration and frequency of attacks are traditionally used to assess the effectiveness of treatments for migraine and other primary headaches. However, recent clinical and therapeutic guidelines and guidelines for conducting clinical trials specify that the essential aim of symptomatic and prophylactic migraine treatments should be to reduce the global impact of the headaches on the patient's life. Some standardised instruments for assessing disability and health-related quality of life seem sensitive to treatment-induced changes in primary headache patients. However, further studies to determine the suitability of these instruments as outcome measures in clinical practice are necessary.

KW - End-point

KW - Migraine

KW - Outcome

KW - Primary headaches

KW - Prophylaxis

KW - Symptomatic treatments

UR - http://www.scopus.com/inward/record.url?scp=16544386465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16544386465&partnerID=8YFLogxK

U2 - 10.1007/s10072-004-0264-x

DO - 10.1007/s10072-004-0264-x

M3 - Article

C2 - 15549515

AN - SCOPUS:16544386465

VL - 25

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - SUPPL. 3

ER -